{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:03:18Z","timestamp":1780034598101,"version":"3.53.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-025-02197-3","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:33:17Z","timestamp":1765949597000},"page":"591-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of outcomes after ablation of atrial fibrillation in patients with heart failure with preserved versus reduced ejection fraction: a US retrospective cohort analysis"],"prefix":"10.1007","volume":"69","author":[{"given":"Ahmed Mazen","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Farid","family":"Gadelmawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qasi","family":"Najah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer","family":"Awashra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerollos","family":"Abdelsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Abdelazeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Felpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Winterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"8","key":"2197_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014;129(8):837\u201347. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.005119.","journal-title":"Circulation"},{"issue":"2","key":"2197_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1747493019897870","volume":"16","author":"G Lippi","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217\u201321. https:\/\/doi.org\/10.1177\/1747493019897870.","journal-title":"Int J Stroke"},{"issue":"4","key":"2197_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.122.057444","volume":"146","author":"YNV Reddy","year":"2022","unstructured":"Reddy YNV, Borlaug BA, Gersh BJ. Management of atrial fibrillation across the spectrum of heart failure with preserved and reduced ejection fraction. Circulation. 2022;146(4):339\u201357. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.057444.","journal-title":"Circulation"},{"key":"2197_CR4","doi-asserted-by":"publisher","first-page":"1137230","DOI":"10.3389\/fpubh.2023.1137230","volume":"11","author":"M Jiao","year":"2023","unstructured":"Jiao M, Liu C, Liu Y, Wang Y, Gao Q, Ma A. Estimates of the global, regional, and national burden of atrial fibrillation in older adults from 1990 to 2019: insights from the Global Burden of Disease study 2019. Front Public Health. 2023;11:1137230. https:\/\/doi.org\/10.3389\/fpubh.2023.1137230.","journal-title":"Front Public Health"},{"issue":"5","key":"2197_CR5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/heartjnl-2021-319122","volume":"108","author":"CD Nicoli","year":"2022","unstructured":"Nicoli CD, O\u2019Neal WT, Levitan EB, Singleton MJ, Judd SE, Howard G, et al. Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction. Heart. 2022;108(5):353\u20139. https:\/\/doi.org\/10.1136\/heartjnl-2021-319122.","journal-title":"Heart"},{"issue":"2","key":"2197_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.hfc.2009.11.001","volume":"6","author":"SA Lubitz","year":"2010","unstructured":"Lubitz SA, Benjamin EJ, Ellinor PT. Atrial fibrillation in congestive heart failure. Heart Fail Clin. 2010;6(2):187\u2013200. https:\/\/doi.org\/10.1016\/j.hfc.2009.11.001.","journal-title":"Heart Fail Clin"},{"issue":"5","key":"2197_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","volume":"133","author":"R Santhanakrishnan","year":"2016","unstructured":"Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133(5):484\u201392. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018614.","journal-title":"Circulation"},{"issue":"5","key":"2197_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1707855.","journal-title":"N Engl J Med"},{"issue":"1","key":"2197_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","volume":"7","author":"RJ Hunter","year":"2014","unstructured":"Hunter RJ, Berriman TJ, Diab I, Kamdar R, Richmond L, Baker V, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circulation: Arrhythmia and Electrophysiology. 2014;7(1):31\u20138. https:\/\/doi.org\/10.1161\/CIRCEP.113.000806.","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"1","key":"2197_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","volume":"149","author":"JA Joglar","year":"2024","unstructured":"Joglar JA, Chung MK, Armbruster AL, Benjamin EJ, Chyou JY, Cronin EM, et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2024;149(1):e1\u2013156. https:\/\/doi.org\/10.1161\/CIR.0000000000001193.","journal-title":"Circulation"},{"issue":"5","key":"2197_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2020","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"key":"2197_CR12","doi-asserted-by":"publisher","first-page":"1423147","DOI":"10.3389\/fcvm.2024.1423147","volume":"11","author":"X Chen","year":"2024","unstructured":"Chen X, Zhang X, Fang X, Feng S. Efficacy and safety of catheter ablation for atrial fibrillation in patients with heart failure with preserved ejection fraction: a systematic review and meta-analysis. Front Cardiovasc Med. 2024;11:1423147. https:\/\/doi.org\/10.3389\/fcvm.2024.1423147.","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"2197_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/jamacardio.2024.0675","volume":"9","author":"A Oraii","year":"2024","unstructured":"Oraii A, McIntyre WF, Parkash R, Kowalik K, Razeghi G, Benz AP, et al. Atrial fibrillation ablation in heart failure with reduced vs preserved ejection fraction: a systematic review and meta-analysis. JAMA Cardiol. 2024;9(6):545\u201355. https:\/\/doi.org\/10.1001\/jamacardio.2024.0675.","journal-title":"JAMA Cardiol"},{"issue":"9","key":"2197_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.124.012926","volume":"17","author":"A Younis","year":"2024","unstructured":"Younis A, Tabaja C, Santangeli P, Nakagawa H, Sipko J, Madden R, et al. Outcomes of atrial fibrillation ablation in heart failure subtypes. Circulation: Arrhythmia and Electrophysiology. 2024;17(9):e012926. https:\/\/doi.org\/10.1161\/CIRCEP.124.012926.","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"7624","key":"2197_CR15","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806\u20138. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD.","journal-title":"BMJ"},{"key":"2197_CR16","unstructured":"Publication Guidelines - TriNetX. Accessed September 2, 2024. https:\/\/trinetx.com\/real-world-resources\/publications\/trinetx-publication-guidelines\/. (n.d.)."},{"issue":"8","key":"2197_CR17","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.jacep.2024.03.031","volume":"10","author":"DI Satti","year":"2024","unstructured":"Satti DI, Karius A, Chan JSK, Isakadze N, Yadav R, Garg K, et al. Effects of glucagon-like peptide-1 receptor agonists on atrial fibrillation recurrence after catheter ablation. JACC: Clinical Electrophysiology. 2024;10(8):1848\u201355. https:\/\/doi.org\/10.1016\/j.jacep.2024.03.031.","journal-title":"JACC: Clinical Electrophysiology"},{"issue":"10","key":"2197_CR18","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.jacep.2023.06.008","volume":"9","author":"MR Abu-Qaoud","year":"2023","unstructured":"Abu-Qaoud MR, Kumar A, Tarun T, Abraham S, Ahmad J, Khadke S, et al. Impact of SGLT2 inhibitors on AF recurrence after catheter ablation in patients with type 2 diabetes. JACC Clin Electrophysiol. 2023;9(10):2109\u201318. https:\/\/doi.org\/10.1016\/j.jacep.2023.06.008.","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"2197_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268\u201374. https:\/\/doi.org\/10.7326\/M16-2607.","journal-title":"Ann Intern Med"},{"issue":"18","key":"2197_CR20","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","volume":"61","author":"DG Jones","year":"2013","unstructured":"Jones DG, Haldar SK, Hussain W, Sharma R, Francis DP, Rahman-Haley SL, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. J Am Coll Cardiol. 2013;61(18):1894\u2013903. https:\/\/doi.org\/10.1016\/j.jacc.2013.01.069.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2197_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.007731","volume":"12","author":"K-H Kuck","year":"2019","unstructured":"Kuck K-H, Merkely B, Zahn R, Arentz T, Seidl K, Schl\u00fcter M, et al. Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial. Circ Arrhythm Electrophysiol. 2019;12(12):e007731. https:\/\/doi.org\/10.1161\/CIRCEP.119.007731.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"17","key":"2197_CR22","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","volume":"133","author":"L Di Biase","year":"2016","unstructured":"Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device. Circulation. 2016;133(17):1637\u201344. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.019406.","journal-title":"Circulation"},{"issue":"6","key":"2197_CR23","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jchf.2023.01.008","volume":"11","author":"D Chieng","year":"2023","unstructured":"Chieng D, Sugumar H, Segan L, Tan C, Vizi D, Nanayakkara S, et al. Atrial fibrillation ablation for heart failure with preserved ejection fraction: a randomized controlled trial. JACC Heart Fail. 2023;11(6):646\u201358. https:\/\/doi.org\/10.1016\/j.jchf.2023.01.008.","journal-title":"JACC Heart Fail"},{"issue":"5","key":"2197_CR24","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jchf.2025.01.029","volume":"13","author":"M Pieter","year":"2025","unstructured":"Pieter M, Nunes AS, Jonas E, Laurent P, Wilfried M, Wilson TWH. Effects of atrial fibrillation ablation for heart failure with preserved ejection fraction. JACC Heart Fail. 2025;13(5):785\u201394. https:\/\/doi.org\/10.1016\/j.jchf.2025.01.029.","journal-title":"JACC Heart Fail"},{"key":"2197_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cells9010242","author":"SJ Simmonds","year":"2020","unstructured":"Simmonds SJ, Cuijpers I, Heymans S, Jones EAV. Cellular and molecular differences between HFpEF and HFrEF: a step ahead in an improved pathological understanding. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9010242.","journal-title":"Cells"},{"issue":"6","key":"2197_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/HAE.0000000000000078","volume":"14","author":"R Gopinathannair","year":"2021","unstructured":"Gopinathannair R, Chen LY, Chung MK, Cornwell WK, Furie KL, Lakkireddy DR, et al. Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American Heart Association. Circ Arrhythm Electrophysiol. 2021;14(6):HAE0000000000000078. https:\/\/doi.org\/10.1161\/HAE.0000000000000078.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"2197_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10840-013-9836-0","volume":"38","author":"M Akkaya","year":"2013","unstructured":"Akkaya M, Roukoz H, Adabag S, Benditt DG, Anand I, Li JM, et al. Improvement of left ventricular diastolic function and left atrial reverse remodeling after catheter ablation of premature ventricular complexes. J Interv Card Electrophysiol. 2013;38(3):179\u201385. https:\/\/doi.org\/10.1007\/s10840-013-9836-0.","journal-title":"J Interv Card Electrophysiol"},{"issue":"1","key":"2197_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12916-023-02764-3","volume":"21","author":"L Fauchier","year":"2023","unstructured":"Fauchier L, Bisson A, Bodin A. Heart failure with preserved ejection fraction and atrial fibrillation: recent advances and open questions. BMC Med. 2023;21(1):54. https:\/\/doi.org\/10.1186\/s12916-023-02764-3.","journal-title":"BMC Med"},{"issue":"3","key":"2197_CR29","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.120.047019","volume":"142","author":"A Pandey","year":"2020","unstructured":"Pandey A, Vaduganathan M, Arora S, Qamar A, Mentz RJ, Shah SJ, et al. Temporal trends in prevalence and prognostic implications of comorbidities among patients with acute decompensated heart failure: the ARIC study community surveillance. Circulation. 2020;142(3):230\u201343. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047019.","journal-title":"Circulation"},{"issue":"21","key":"2197_CR30","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","volume":"64","author":"RJ Mentz","year":"2014","unstructured":"Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CSP, Cowie MR, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014;64(21):2281\u201393. https:\/\/doi.org\/10.1016\/j.jacc.2014.08.036.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2197_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.119.042996","volume":"141","author":"M Packer","year":"2020","unstructured":"Packer M, Lam CSP, Lund LH, Redfield MM. Interdependence of atrial fibrillation and heart failure with a preserved ejection fraction reflects a common underlying atrial and ventricular myopathy. Circulation. 2020;141(1):4\u20136. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.042996.","journal-title":"Circulation"},{"issue":"6","key":"2197_CR32","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/CIRCHEARTFAILURE.114.001276","volume":"7","author":"A Rossi","year":"2014","unstructured":"Rossi A, Gheorghiade M, Triposkiadis F, Solomon SD, Pieske B, Butler J. Left atrium in heart failure with preserved ejection fraction: structure, function, and significance. Circ Heart Fail. 2014;7(6):1042\u20139. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001276.","journal-title":"Circ Heart Fail"},{"issue":"8","key":"2197_CR33","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","volume":"5","author":"U Sartipy","year":"2017","unstructured":"Sartipy U, Dahlstr\u00f6m U, Fu M, Lund LH. Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction. JACC Heart Fail. 2017;5(8):565\u201374. https:\/\/doi.org\/10.1016\/j.jchf.2017.05.001.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"2197_CR34","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jjcc.2015.10.008","volume":"68","author":"T-H Kim","year":"2016","unstructured":"Kim T-H, Shim CY, Park JH, Nam CM, Uhm J-S, Joung B, et al. Left ventricular diastolic dysfunction is associated with atrial remodeling and risk or presence of stroke in patients with paroxysmal atrial fibrillation. J Cardiol. 2016;68(2):104\u20139. https:\/\/doi.org\/10.1016\/j.jjcc.2015.10.008.","journal-title":"J Cardiol"},{"key":"2197_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009294","author":"S Arora","year":"2018","unstructured":"Arora S, Lahewala S, Tripathi B, Mehta V, Kumar V, Chandramohan D, et al. Causes and predictors of readmission in patients with atrial fibrillation undergoing catheter ablation: a national population-based cohort study. J Am Heart Assoc. 2018. https:\/\/doi.org\/10.1161\/JAHA.118.009294.","journal-title":"J Am Heart Assoc"},{"key":"2197_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd11020035","author":"N Kataoka","year":"2024","unstructured":"Kataoka N, Imamura T, Koi T, Uchida K, Kinugawa K. Adverse events requiring hospitalization following catheter ablation for atrial fibrillation in heart failure with versus without systolic dysfunction. J Cardiovasc Dev Dis. 2024. https:\/\/doi.org\/10.3390\/jcdd11020035.","journal-title":"J Cardiovasc Dev Dis"},{"key":"2197_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081240","author":"L Schrutka","year":"2019","unstructured":"Schrutka L, Seirer B, Duca F, Binder C, Dalos D, Kammerlander A, et al. Patients with heart failure and preserved ejection fraction are at risk of gastrointestinal bleeding. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8081240.","journal-title":"J Clin Med"},{"issue":"1","key":"2197_CR38","volume":"9","author":"J Yu","year":"2025","unstructured":"Yu J, Zhou G, Guo Y, Long Y. Inflammation in heart failure: mechanisms and therapeutic strategies. Cardiovasc Innov Appl. 2025;9(1):922.","journal-title":"Cardiovasc Innov Appl"},{"issue":"2","key":"2197_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006541","volume":"13","author":"R R\u00f8rth","year":"2020","unstructured":"R\u00f8rth R, Jhund PS, Yilmaz MB, Kristensen SL, Welsh P, Desai AS, et al. Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction. Circ Heart Fail. 2020;13(2):e006541. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.119.006541.","journal-title":"Circ Heart Fail"},{"issue":"4","key":"2197_CR40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12471-016-0817-7","volume":"24","author":"WC Meijers","year":"2016","unstructured":"Meijers WC, van der Velde AR, de Boer RA. Biomarkers in heart failure with preserved ejection fraction. Neth Heart J. 2016;24(4):252\u20138. https:\/\/doi.org\/10.1007\/s12471-016-0817-7.","journal-title":"Neth Heart J"},{"issue":"1","key":"2197_CR41","doi-asserted-by":"publisher","first-page":"2","DOI":"10.5837\/bjc.2024.002","volume":"31","author":"H Birrell","year":"2024","unstructured":"Birrell H, Isles C, Fersia O, Anwar M, Mondoa C, McFadyen A. Assessment of the diagnostic value of NT-proBNP in heart failure with preserved ejection fraction. Br J Cardiol. 2024;31(1):2. https:\/\/doi.org\/10.5837\/bjc.2024.002.","journal-title":"Br J Cardiol"},{"key":"2197_CR42","unstructured":"Golla MSG, Hajouli S, L. D. (n.d.). Heart Failure and Ejection Fraction. [Updated 2024 May 5]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553115\/."}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-02197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-025-02197-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-025-02197-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:39:47Z","timestamp":1780033187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10840-025-02197-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2197"],"URL":"https:\/\/doi.org\/10.1007\/s10840-025-02197-3","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Due to the deidentified nature of the platform's patient data and HCOs in compliance with the Section \u00a7164.514 of the HIPAA Privacy Rule, ethical approval was deemed unnecessary. The study complied with the ethical and reporting standards depicted by the TriNetX platform under \u201cPublication Guidelines\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Rachel M. Kaplan: consulting: Abbott, Medtronic, Boston Scientific and Royalties from Uptodate. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}